Literature DB >> 2515056

Characterization of the defective beta-glucuronidase activity in canine mucopolysaccharidosis type VII.

E H Schuchman1, T K Toroyan, M E Haskins, R J Desnick.   

Abstract

Canine mucopolysaccharidosis type VII results from deficient activity of lysosomal beta-glucuronidase. Residual enzymatic activity (0.2-1.7% of normal) was detected in tissue homogenates from affected dogs. In contrast, serum and urine from affected animals had up to 15% residual activity. To further characterize the nature of the defective enzyme, hepatic beta-glucuronidase was partially purified from normal and MPS VII dogs for determination of their physical and kinetic properties. About 65% of the total beta-glucuronidase in normal canine liver required detergent for solubilization (i.e., membrane-associated), whereas only 22% of the residual activity in canine MPS VII liver was membrane-associated. Compared to the normal hepatic enzyme, the Km towards 4-methylumbelliferyl-beta-glucuronide was markedly increased in MPS VII dogs (i.e., 0.48 versus greater than 2.5 mmol/l). In contrast, the thermo-, cryo-, and pH stability properties, as well as the pH optimum (approximately 4.6), were essentially unaffected. In addition, the canine MPS VII hepatic residual activity was unresponsive to sulfhydryl reducing reagents and divalent cations, despite the fact that incubation of normal canine beta-glucuronidase with dithiothreitol and magnesium and/or calcium enhanced the activity more than 15-fold.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2515056     DOI: 10.1159/000469027

Source DB:  PubMed          Journal:  Enzyme        ISSN: 0013-9432


  5 in total

1.  Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.

Authors:  Nicolas Serratrice; Aurelie Cubizolle; Sandy Ibanes; Nadine Mestre-Francés; Neus Bayo-Puxan; Sophie Creyssels; Aurelie Gennetier; Florence Bernex; Jean-Michel Verdier; Mark E Haskins; Guilhem Couderc; Francois Malecaze; Vasiliki Kalatzis; Eric J Kremer
Journal:  J Control Release       Date:  2014-03-04       Impact factor: 9.776

Review 2.  Lysosomal storage diseases: mechanisms of enzyme replacement therapy.

Authors:  G Bou-Gharios; D Abraham; I Olsen
Journal:  Histochem J       Date:  1993-09

3.  Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer.

Authors:  J H Wolfe; E H Schuchman; L E Stramm; E A Concaugh; M E Haskins; G D Aguirre; D F Patterson; R J Desnick; E Gilboa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Mucopolysaccharidosis type VII (Sly syndrome). Beta-glucuronidase-deficient mucopolysaccharidosis in the dog.

Authors:  M E Haskins; G D Aguirre; P F Jezyk; E H Schuchman; R J Desnick; D F Patterson
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

Review 5.  Canine and Feline Models of Human Genetic Diseases and Their Contributions to Advancing Clinical Therapies
.

Authors:  Brittney L Gurda; Allison M Bradbury; Charles H Vite
Journal:  Yale J Biol Med       Date:  2017-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.